Andreas Fibig to leave Bayer HealthCare Pharmaceuticals
"With his experience and his commitment, Andreas Fibig has advanced the very positive development of our Pharmaceuticals business over the past years making it to one of the fastest growing pharmaceutical companies in the industry," said Olivier Brandicourt, CEO of Bayer HealthCare. "We thank him and wish him all the best for his next step in his career and his future."
The company will announce a successor for Andreas Fibig in a few days.
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.